https://old.international-pharma.com/smc-expands-guidance-for-lokelma-to-emergency-care-settings/ 2023-10-19T22:41:59+00:00 https://old.international-pharma.com/eit-healths-venture-centre-of-excellence-in-link-up-with-productlife/ 2023-10-19T22:41:58+00:00 https://old.international-pharma.com/cphi-excellence-in-pharma-award-winners-2022-2/ 2023-10-19T22:41:57+00:00 https://old.international-pharma.com/cphi-frankfurt-2022-global-pharma-confidence-hits-record-high-in-the-annual-cphi-pharma-index/ 2023-10-19T22:41:57+00:00 https://old.international-pharma.com/wp-content/uploads/2022/11/Screenshot-2022-11-11-at-11.50.28.png https://old.international-pharma.com/wp-content/uploads/2022/11/2.png https://old.international-pharma.com/wp-content/uploads/2022/11/3.png https://old.international-pharma.com/bristol-myers-squibb-opens-125-acre-biologics-campus-in-dublin/ 2023-10-19T22:41:56+00:00 https://old.international-pharma.com/stada-and-xbrane-gain-eu-approval-for-biosimilar-ximluci/ 2023-10-19T22:41:55+00:00 https://old.international-pharma.com/priothera-reveals-positive-mocravimod-data/ 2023-10-19T22:41:51+00:00 https://old.international-pharma.com/lindis-biotech-presents-encouraging-data-from-bladder-cancer-trial/ 2023-10-19T22:41:50+00:00 https://old.international-pharma.com/norfolk-and-norwich-university-hospitals-establishes-therapy-for-ovarian-cancer-patients/ 2023-10-19T22:41:49+00:00 https://old.international-pharma.com/sequana-announces-results-from-study-of-direct-sodium-removal/ 2023-10-19T22:41:48+00:00 https://old.international-pharma.com/provention-bio-wins-approval-for-first-in-class-diabetes-drug/ 2023-10-19T22:41:48+00:00 https://old.international-pharma.com/astrazeneca-to-donate-10000-doses-of-flu-vaccine/ 2023-10-19T22:41:47+00:00 https://old.international-pharma.com/genmab-abbvie-grab-priority-review-for-cancer-bispecific-antibody/ 2023-10-19T22:41:46+00:00 https://old.international-pharma.com/infex-begins-study-of-pseudomonas-aeruginosa-candidate-resp-x/ 2023-10-19T22:41:45+00:00 https://old.international-pharma.com/turbine-boosts-ai-platform-to-deliver-cancer-treatments/ 2023-10-19T22:41:45+00:00 https://old.international-pharma.com/takeda-findings-may-minimise-haemophilia-treatment-side-effects/ 2023-10-19T22:41:44+00:00 https://old.international-pharma.com/multi-drug-precision-medicine-cancer-trial-begins/ 2023-10-19T22:41:39+00:00 https://old.international-pharma.com/storm-doses-first-patient-with-solid-tumour-drug-candidate/ 2023-10-19T22:41:39+00:00 https://old.international-pharma.com/depressive-therapy-spravato-demonstrates-superior-efficacy/ 2023-10-19T22:41:38+00:00 https://old.international-pharma.com/bristol-myers-squibb-immunotherapy-chemo-combination-gets-nice-recommendation/ 2023-10-19T22:41:37+00:00 https://old.international-pharma.com/c4xd-signs-nrf2-activator-deal-with-astrazeneca/ 2023-10-19T22:41:36+00:00 https://old.international-pharma.com/almirall-joins-project-to-allow-study-participants-to-use-trial-data/ 2023-10-19T22:41:36+00:00 https://old.international-pharma.com/merck-kgaas-arpraziquantel-validated-by-european-medicines-agency/ 2023-10-19T22:41:34+00:00 https://old.international-pharma.com/valneva-and-pfizer-report-lyme-disease-antibody-data/ 2023-10-19T22:41:33+00:00 https://old.international-pharma.com/fda-grants-fast-track-designation-for-istessos-ipf-candidate/ 2023-10-19T22:41:32+00:00 https://old.international-pharma.com/valneva-shares-positive-chikungunya-vaccine-results/ 2023-10-19T22:41:28+00:00 https://old.international-pharma.com/spago-nanomedical-begins-endometriosis-study/ 2023-10-19T22:41:27+00:00 https://old.international-pharma.com/leo-pharma-reveal-positive-results-from-delgocitinib-research/ 2023-10-19T22:41:27+00:00 https://old.international-pharma.com/curricula-then-and-now-an-environmental-scan-and-recommendations/ 2023-10-19T22:41:26+00:00 https://old.international-pharma.com/highlights-from-the-fiped-global-education-report/ 2023-10-19T22:41:25+00:00 https://old.international-pharma.com/pharmaceutical-education-in-india-past-present-and-future/ 2023-10-19T22:41:24+00:00 https://old.international-pharma.com/cphi-frankfurt-returns-to-pre-pandemic-strength-as-pharma-industry-booms-again/ 2023-10-19T22:41:23+00:00 https://old.international-pharma.com/wp-content/uploads/2022/12/CPHI-Frankfurt.jpg https://old.international-pharma.com/pharmaceutical-education-in-the-south-african-multicultural-society/ 2023-10-19T22:41:23+00:00 https://old.international-pharma.com/novadip-reveals-results-from-severe-bone-non-union-trial/ 2023-10-19T22:41:22+00:00 https://old.international-pharma.com/catalent-completes-cell-therapy-manufacturing-facilities-in-belgium/ 2023-10-19T22:41:21+00:00 https://old.international-pharma.com/positive-results-for-ampheras-mesopher-cell-therapy/ 2023-10-19T22:41:17+00:00 https://old.international-pharma.com/kidney-research-uk-concerned-by-nice-process/ 2023-10-19T22:41:16+00:00 https://old.international-pharma.com/novartis-joins-cancer-research-uk-on-rare-cancers-study/ 2023-10-19T22:41:15+00:00 https://old.international-pharma.com/new-online-certified-course-gain-expertise-in-gmp-for-medical-devices-and-fda-21-cfr-part-820/ 2023-10-19T22:41:14+00:00 https://old.international-pharma.com/wp-content/uploads/2022/12/GMP-Medical-Devices.png https://old.international-pharma.com/scottish-medicines-consortium-agrees-to-use-of-rinvoq/ 2023-10-19T22:41:14+00:00 https://old.international-pharma.com/minervax-reveals-financing-to-development-group-b-streptococcus-vaccine/ 2023-10-19T22:41:13+00:00 https://old.international-pharma.com/pfizer-and-anumana-boost-detection-of-cardiovascular-disease/ 2023-10-19T22:41:12+00:00 https://old.international-pharma.com/astrazenecas-forxiga-recommended-in-eu-for-chronic-heart-failure/ 2023-10-19T22:41:11+00:00 https://old.international-pharma.com/verona-pharmas-ensifentrine-meets-copd-objectives/ 2023-10-19T22:41:10+00:00 https://old.international-pharma.com/hvivo-delivers-promising-results-for-imutexs-mosquito-vaccine/ 2023-10-19T22:41:10+00:00 https://old.international-pharma.com/gilead-gets-fda-nod-for-multi-drug-resistant-hiv-treatment/ 2023-10-19T22:41:05+00:00 https://old.international-pharma.com/mainz-recruits-first-patient-into-biomarker-research/ 2023-10-19T22:41:05+00:00 https://old.international-pharma.com/moderna-to-expand-uk-manufacturing-capabilities/ 2023-10-19T22:41:04+00:00 https://old.international-pharma.com/amgen-inks-1-25b-adcs-deal-with-legochem-biosciences/ 2023-10-19T22:41:03+00:00 https://old.international-pharma.com/tg-therapeutics-grabs-fda-approval-for-ms-drug/ 2023-10-19T22:41:02+00:00 https://old.international-pharma.com/fda-says-not-yet-to-ipsen-rare-bone-disease-drug/ 2023-10-19T22:41:02+00:00 https://old.international-pharma.com/novavax-begins-phase-2-trial-for-combo-influenza-covid-jab/ 2023-10-19T22:41:01+00:00 https://old.international-pharma.com/tower-expands-pharmaceutical-corridors-with-new-singapore-site/ 2023-10-19T22:41:00+00:00 https://old.international-pharma.com/wp-content/uploads/2023/01/Tower-Cold-Chain-New-Singapore-Office-1.jpg https://old.international-pharma.com/biontech-forms-cancer-immunotherapies-partnership-with-uk-government/ 2023-10-19T22:40:59+00:00 https://old.international-pharma.com/transgene-receives-approval-to-begin-oncolytic-virus-trial/ 2023-10-19T22:40:58+00:00 https://old.international-pharma.com/astrazeneca-makes-cincor-pharma-acquisition/ 2023-10-19T22:40:54+00:00 https://old.international-pharma.com/artificial-pancreas-technology-set-to-change-lives/ 2023-10-19T22:40:53+00:00 https://old.international-pharma.com/sarepta-and-catalent-expand-manufacturing-deal-ahead-of-dmd-gene-therapy-approval/ 2023-10-19T22:40:52+00:00 https://old.international-pharma.com/how-the-pharmaceutical-industry-can-navigate-supply-chain-disruptions-and-gain-resiliency/ 2023-10-19T22:40:51+00:00 https://old.international-pharma.com/overcoming-the-pitfalls-of-pre-filled-syringe-filling/ 2023-10-19T22:40:50+00:00 https://old.international-pharma.com/artificial-intelligence-is-a-core-pillar-in-the-evolution-of-digital-health-and-patient-centric-solutions/ 2023-10-19T22:40:50+00:00 https://old.international-pharma.com/whats-next-for-pharmaceutical-serialisation/ 2023-10-19T22:40:49+00:00 https://old.international-pharma.com/demand-design-delivery-high-potent-packaging-at-pci-pharma-services/ 2023-10-19T22:40:48+00:00 https://old.international-pharma.com/the-challenges-of-increased-complexity-in-api-development-and-manufacture/ 2023-10-19T22:40:47+00:00 https://old.international-pharma.com/nces-and-api-quality-by-design/ 2023-10-19T22:40:47+00:00 https://old.international-pharma.com/pharmaceutical-tablet-coating-achieving-perfect-coating-uniformity/ 2023-10-19T22:40:42+00:00 https://old.international-pharma.com/strategic-intellectual-property-considerations-for-protecting-ai-innovations-in-life-sciences/ 2023-10-19T22:40:41+00:00 https://old.international-pharma.com/data-driven-processes-overtake-structured-document-authoring/ 2023-10-19T22:40:41+00:00 https://old.international-pharma.com/ip-issues-surrounding-machine-learning-and-ai-in-the-pharmaceutical-space/ 2023-10-19T22:40:40+00:00 https://old.international-pharma.com/respiratory-disease-management-a-connected-approach/ 2023-10-19T22:40:39+00:00 https://old.international-pharma.com/pre-existing-immunogenicity-how-will-cell-and-gene-therapies-change-our-testing-approach/ 2023-10-19T22:40:38+00:00 https://old.international-pharma.com/strategies-to-reduce-cold-chain-burden-in-biopharmaceuticals/ 2023-10-19T22:40:38+00:00 https://old.international-pharma.com/technical-advancements-in-proteomics-streamline-high-throughput-workflows/ 2023-10-19T22:40:37+00:00 https://old.international-pharma.com/opportunities-for-the-ipo-of-psychedelics-companies-or-how-to-change-investors-minds/ 2023-10-19T22:40:36+00:00 https://old.international-pharma.com/regulatory-and-developmental-complexities-around-demonstrating-bioequivalence-for-a-topical-generic-product/ 2023-10-19T22:40:35+00:00 https://old.international-pharma.com/driving-a-vision-for-a-data-driven-regulatory-ecosystem/ 2023-10-19T22:40:31+00:00 https://old.international-pharma.com/bad-medicine-lessons-from-an-enduring-alliance-between-big-pharma-and-global-policing/ 2023-10-19T22:40:30+00:00 https://old.international-pharma.com/brexit-impact-challenges-and-solutions-for-the-pharmaceutical-industry/ 2023-10-19T22:40:29+00:00 https://old.international-pharma.com/understanding-compliance-moving-from-cost-to-value/ 2023-10-19T22:40:28+00:00 https://old.international-pharma.com/eu-ctr-final-countdown-what-you-need-to-know/ 2023-10-19T22:40:28+00:00 https://old.international-pharma.com/answering-pharmas-need-for-outsourcing-to-process-intensification-technology-for-the-future-of-biopharmaceutical-production/ 2023-10-19T22:35:06+00:00 https://old.international-pharma.com/wp-content/uploads/2012/09/Bertin2.jpg https://old.international-pharma.com/researchers-find-pcsk9-inhibitors-could-treat-abdominal-aortic-aneurysms/ 2023-10-18T08:31:11+00:00 https://old.international-pharma.com/ucl-study-suggests-changes-to-improve-mri-scans-for-prostate-cancer/ 2023-10-18T08:29:30+00:00 https://old.international-pharma.com/ucl-researchers-recommend-ai-language-models-for-schizophrenia-diagnosis/ 2023-10-18T08:26:36+00:00 https://old.international-pharma.com/ukri-awards-three-projects-25m-for-vaccine-development/ 2023-10-18T08:24:27+00:00 https://old.international-pharma.com/astronautx-completes-48m-series-a-financing-for-alzheimers-disease/ 2023-10-18T08:21:56+00:00 https://old.international-pharma.com/university-of-edinburgh-to-lead-new-exascale-supercomputer/ 2023-10-18T08:20:12+00:00 https://old.international-pharma.com/king-faisal-specialist-and-research-centre-achieves-world-first-fully-robotic-liver-transplant/ 2023-10-10T13:14:04+00:00 https://old.international-pharma.com/ukri-awards-41m-to-enhance-uk-research-and-innovation/ 2023-10-10T13:11:12+00:00 https://old.international-pharma.com/new-university-of-bristol-study-to-aid-strep-a-vaccine-development/ 2023-10-10T13:08:26+00:00 https://old.international-pharma.com/uk-launches-its-first-national-pet-imaging-platform-for-drug-discovery/ 2023-10-10T13:05:49+00:00 https://old.international-pharma.com/astrazeneca-reveals-new-research-to-improve-drug-discovery/ 2023-10-10T13:03:13+00:00 https://old.international-pharma.com/stoelzle-pharma/ 2023-10-10T10:16:40+00:00 https://old.international-pharma.com/wp-content/uploads/2023/10/Stoelzle-Pharma_Group-Image_pharma-bottles.jpg https://old.international-pharma.com/wp-content/uploads/2023/10/Stoelzle-Pharma_ecosecur_image.png https://old.international-pharma.com/wp-content/uploads/2023/10/Stoelzle_Pharmacos-Line_Image-scaled.jpg https://old.international-pharma.com/drug-discovery-2023/ 2023-10-05T13:28:42+00:00 https://old.international-pharma.com/wp-content/uploads/2023/10/ELRIG-DD23-reg_instagram-2.jpg https://old.international-pharma.com/abbvie-roche-drug-disappoints-in-phase-3-multiple-myeloma-trial/ 2023-10-03T12:36:48+00:00 https://old.international-pharma.com/nihr-awards-97-5m-to-fund-its-new-research-support-service/ 2023-10-03T12:33:14+00:00 https://old.international-pharma.com/vortex-expands-research-at-london-cancer-hubs-innovation-gateway/ 2023-10-03T12:30:25+00:00 https://old.international-pharma.com/nera-economic-consulting-raises-concerns-over-dhscs-statutory-scheme/ 2023-10-03T12:27:13+00:00 https://old.international-pharma.com/fewer-ms-patients-are-prescribed-dmts-in-uk-compared-to-europe/ 2023-10-03T10:48:47+00:00 https://old.international-pharma.com/rethink-redesign-recycle-pharmas-100-pet-blister/ 2023-09-29T13:01:52+00:00 https://old.international-pharma.com/a-new-age-of-pharmaceutical-innovation/ 2023-09-29T12:57:26+00:00 https://old.international-pharma.com/enhancing-clinical-succes-during-early-development/ 2023-09-29T12:52:52+00:00 https://old.international-pharma.com/integrated-cdmo-partner-for-parenteral-drug-products/ 2023-09-29T12:48:59+00:00 https://old.international-pharma.com/5-steps-to-improving-pharmacovigilance-system-master-file-psmf-management/ 2023-09-29T12:43:15+00:00 https://old.international-pharma.com/why-pharma-dealmaking-is-a-sector-thats-ripe-for-growth/ 2023-09-29T12:39:30+00:00 https://old.international-pharma.com/antibody-drug-conjugates-and-the-link-to-fighting-cancer/ 2023-09-29T12:35:14+00:00 https://old.international-pharma.com/promising-advances-in-plasma-proteomics-for-early-disease-detection-and-personalised-treatments/ 2023-09-29T12:30:55+00:00 https://old.international-pharma.com/high-efficiency-safety-profile-for-recurrent-vaginitis-and-biofilm-treatment/ 2023-09-29T12:25:56+00:00 https://old.international-pharma.com/keeping-ecoas-off-the-critical-path-key-considerations/ 2023-09-29T12:19:34+00:00 https://old.international-pharma.com/can-a-modular-approach-to-cleanroom-technology-deliver-flexible-sterile-manufacturing-capacity/ 2023-09-29T12:15:16+00:00 https://old.international-pharma.com/at-last-the-advent-of-better-software-application-ux-to-manage-critical-manufacturing-processes-in-highly-regulated-industries/ 2023-09-29T12:11:21+00:00 https://old.international-pharma.com/tablet-coating-optimal-uniformity-and-flexibility-tablet-coater-saves-resources/ 2023-09-29T12:07:02+00:00 https://old.international-pharma.com/how-to-make-the-grade-in-pharma-manufacturing/ 2023-09-29T12:01:36+00:00 https://old.international-pharma.com/high-potent-manufacture/ 2023-09-29T11:57:26+00:00 https://old.international-pharma.com/addressing-the-challenges-of-serialisation/ 2023-09-29T11:50:54+00:00 https://old.international-pharma.com/what-does-the-future-hold-for-delayed-releaseempty-hard-capsules/ 2023-09-29T11:02:44+00:00 https://old.international-pharma.com/chemical-recycled-abs-materials-for-the-transition-to-a-circular-economy-model/ 2023-09-29T10:58:40+00:00 https://old.international-pharma.com/navigating-the-shift-in-pharmaceutical-packaging/ 2023-09-29T10:55:21+00:00 https://old.international-pharma.com/taking-healthcare-out-of-the-hospital-how-device-design-can-empower-users/ 2023-09-29T10:51:40+00:00 https://old.international-pharma.com/nanoformulation-for-enhanced-drug-delivery-and-better-patient-compliance/ 2023-09-29T10:42:13+00:00 https://old.international-pharma.com/through-the-lens-of-human-factors-developing-connected-drug-delivery-devices/ 2023-09-29T10:35:54+00:00 https://old.international-pharma.com/pharmaceutical-cold-chain-risks-and-how-to-mitigate-them/ 2023-09-29T10:28:14+00:00 https://old.international-pharma.com/putting-safety-at-the-heart-of-supplier-controls/ 2023-09-29T10:23:45+00:00 https://old.international-pharma.com/what-does-the-future-of-temperature-controlled-pharmasupply-chain-look-like-and-how-do-we-shape-it/ 2023-09-29T10:19:20+00:00 https://old.international-pharma.com/the-great-why-questions-about-dry-powder-inhalers/ 2023-09-29T10:13:05+00:00 https://old.international-pharma.com/clinical-gamma-scintigraphy-for-the-evaluation-of-inhaled-medicine/ 2023-09-29T10:06:20+00:00 https://old.international-pharma.com/vaping-success-or-disaster/ 2023-09-29T09:54:58+00:00 https://old.international-pharma.com/why-an-outcome-driven-approach-to-supply-chain-is-a-strategic-advantage-for-pharmaceutical-businesses/ 2023-09-29T09:45:36+00:00 https://old.international-pharma.com/harnessing-the-power-of-cmaas-in-pharma-logistics/ 2023-09-29T09:45:07+00:00 https://old.international-pharma.com/net-zero-healthcare-priorities-for-decarbonising-the-pharma-supply-chain/ 2023-09-29T09:44:39+00:00 https://old.international-pharma.com/artificial-intelligence-is-a-core-pillar-in-the-evolution-of-digital-health-and-patient-centric-solutions-2/ 2023-09-29T09:44:04+00:00 https://old.international-pharma.com/choosing-and-developing-user-friendly-osmotic-laxatives-for-a-more-patient-centric-portfolio-2/ 2023-09-29T09:43:29+00:00 https://old.international-pharma.com/effective-operations-for-risk-reduction-and-supply-chain-resilience/ 2023-09-29T09:43:00+00:00 https://old.international-pharma.com/potent-product-manufacturing-in-a-multi-product-facility/ 2023-09-29T09:42:26+00:00 https://old.international-pharma.com/individual-device-identification-coding-and-marking-for-the-new-dimension-in-patient-health-and-safety/ 2023-09-29T09:27:31+00:00 https://old.international-pharma.com/cutting-edge-formulation-is-needed-to-enable-the-next-generation-of-oral-biologics/ 2023-09-29T09:26:55+00:00 https://old.international-pharma.com/the-future-of-ai-in-biotechnology/ 2023-09-29T09:25:51+00:00 https://old.international-pharma.com/in-flight-data-control/ 2023-09-29T09:25:07+00:00 https://old.international-pharma.com/accessibility-in-rare-disease-paediatric-clinical-trials/ 2023-09-29T09:24:18+00:00 https://old.international-pharma.com/gene-edited-ipscs-may-find-a-place-in-allogeneic-therapies/ 2023-09-29T09:23:09+00:00 https://old.international-pharma.com/advancements-of-gene-editing-technologiescrispr-cas9/ 2023-09-29T09:20:37+00:00 https://old.international-pharma.com/how-to-harness-the-benefits-of-inhalationwhen-re-formulating-biologics/ 2023-09-29T09:20:02+00:00 https://old.international-pharma.com/unlocking-the-potential-of-drug-discovery-labswith-automation/ 2023-09-29T09:19:26+00:00 https://old.international-pharma.com/serving-the-0-05-of-patients-living-with-a-rare-disease/ 2023-09-29T09:18:51+00:00 https://old.international-pharma.com/vaccine-regulation-in-india/ 2023-09-29T09:18:17+00:00 https://old.international-pharma.com/the-four-trends-set-to-disrupt-highly-regulated-industries-in-2023/ 2023-09-29T09:17:42+00:00 https://old.international-pharma.com/ipi-speaks-with-pharmalexs-local-affiliate-services-lead-on-the-rapidly-changing-global-market/ 2023-09-29T09:17:08+00:00 https://old.international-pharma.com/introducing-a-new-era-in-hplc/ 2023-09-29T09:13:59+00:00 https://old.international-pharma.com/acg-appoints-borja-guerra-as-vice-president-of-international-sales-at-acg-engineering/ 2023-09-28T10:38:00+00:00 https://old.international-pharma.com/wp-content/uploads/2023/09/ACG_Borja_Guerra-scaled.jpeg https://old.international-pharma.com/oxford-biodynamics-launches-prostate-screening-test/ 2023-09-27T09:39:27+00:00 https://old.international-pharma.com/ukhsa-reaches-vaccine-deal-with-csl-seqirus/ 2023-09-27T09:37:46+00:00 https://old.international-pharma.com/seagen-and-astellas-announce-results-from-ev-302-study/ 2023-09-27T09:35:42+00:00 https://old.international-pharma.com/evaxion-and-afrigen-biologics-to-develop-mrna-vaccine-for-gonorrhoea/ 2023-09-27T09:31:59+00:00 https://old.international-pharma.com/uk-government-launches-pathway-for-innovative-technologies/ 2023-09-27T09:30:36+00:00 https://old.international-pharma.com/dive-into-the-pharmaceutical-world-with-pharmap-2024/ 2023-09-26T09:18:53+00:00 https://old.international-pharma.com/wp-content/uploads/2023/09/Pharmap.jpg https://old.international-pharma.com/the-pharmaceutical-manufacturing-and-packaging-congress-2024/ 2023-09-26T09:10:54+00:00 https://old.international-pharma.com/evaxion-validates-its-infectious-disease-ai-vaccine-platform/ 2023-09-20T09:05:23+00:00 https://old.international-pharma.com/beigene-and-nona-biosciences-expand-collaboration-for-antibody-discovery/ 2023-09-20T09:03:47+00:00 https://old.international-pharma.com/pfizers-vydura-recommended-by-nice-for-acute-migraines/ 2023-09-20T09:01:20+00:00 https://old.international-pharma.com/fda-approves-pfizer-biontech-and-modernas-adapted-covid-19-vaccines/ 2023-09-20T08:58:47+00:00 https://old.international-pharma.com/mits-new-technique-to-remotely-evaluate-cerebral-palsy-patients/ 2023-09-20T08:56:20+00:00 https://old.international-pharma.com/novo-nordisk-pharmatech-a-s/ 2023-09-15T10:18:31+00:00 https://old.international-pharma.com/wp-content/uploads/2023/09/Novo-Nordisk_Site_fra-kysten_4-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2023/09/Novo-Nordisk_BKC-95-2.jpg https://old.international-pharma.com/elrig-uk-establishes-engagement-strategy-work-group/ 2023-09-14T12:24:30+00:00 https://old.international-pharma.com/wp-content/uploads/2023/09/ELRIG-ESWG.png https://old.international-pharma.com/salipro-biotech-and-sumitomo-pharma-collaborate-for-drug-discovery/ 2023-09-12T14:28:36+00:00 https://old.international-pharma.com/microplate-dx-secures-2-5m-for-rapid-diagnostic-technology-development/ 2023-09-12T14:25:44+00:00 https://old.international-pharma.com/brainomixs-e-lung-enters-tipal-trial/ 2023-09-12T14:23:55+00:00 https://old.international-pharma.com/amo-pharma-reveals-data-from-myotonic-dystrophy-study/ 2023-09-12T14:20:21+00:00 https://old.international-pharma.com/ariceum-doses-first-patient-with-satoreotide/ 2023-09-12T14:17:43+00:00 https://old.international-pharma.com/neuroplast-spinal-cord-injury-study-milestone/ 2023-09-12T14:15:53+00:00 https://old.international-pharma.com/tower-continues-innovation-streak-with-new-product-launch-at-cphi-barcelona/ 2023-09-06T13:33:19+00:00 https://old.international-pharma.com/wp-content/uploads/2023/09/Tower-Cold-Chain-CPHI-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2023/09/Tower_Passive-temperature-controlled-container-range-Tower-Cold-Chain.jpg https://old.international-pharma.com/theragenix-to-receive-powdered-gene-therapy-grant/ 2023-09-05T14:14:32+00:00 https://old.international-pharma.com/intelligent-omics-partners-with-janssen-on-ai-driven-research/ 2023-09-05T14:12:35+00:00 https://old.international-pharma.com/twist-bioscience-and-ono-pharmaceutical-collaborate/ 2023-09-05T14:11:03+00:00 https://old.international-pharma.com/ucb-announces-approval-of-bimzelx/ 2023-09-05T14:08:53+00:00 https://old.international-pharma.com/novartis-reveals-vital-leqvio-data/ 2023-09-05T14:07:24+00:00 https://old.international-pharma.com/bio-europe/ 2023-09-04T08:49:26+00:00 https://old.international-pharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-2-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-1-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-3-scaled.jpg https://old.international-pharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-4-scaled.jpg https://old.international-pharma.com/sandozs-tyruko-biosimilar-granted-fda-approval-to-treat-relapsing-ms/ 2023-08-29T09:51:20+00:00 https://old.international-pharma.com/fda-grants-odd-to-nexcellas-multiple-myeloma-treatment/ 2023-08-29T09:49:25+00:00 https://old.international-pharma.com/astrazenecas-soliris-approved-in-japan-for-paediatric-gmg-patients/ 2023-08-29T09:46:16+00:00 https://old.international-pharma.com/pfizers-maternal-rsv-vaccine-receives-fda-approval/ 2023-08-29T09:44:38+00:00 https://old.international-pharma.com/gsk-shares-promising-results-from-shingles-vaccine-trial/ 2023-08-29T09:42:26+00:00 https://old.international-pharma.com/research-shows-new-technique-could-cut-time-to-detect-polio-in-half/ 2023-08-22T15:19:04+00:00 https://old.international-pharma.com/nice-recommends-amryts-filsuvez-for-a-rare-skin-disorder/ 2023-08-22T15:17:32+00:00 https://old.international-pharma.com/alligator-bioscience-gains-orphan-designation-for-mitazalimab/ 2023-08-22T15:16:22+00:00 https://old.international-pharma.com/leo-receives-marketing-authorisation-application-for-delgocitinib/ 2023-08-22T15:15:01+00:00 https://old.international-pharma.com/men-with-enlarged-prostates-offered-robotic-treatment-by-fourth-university-hospital/ 2023-08-22T15:13:43+00:00 https://old.international-pharma.com/series-of-new-security-seals-for-screw-caps-provide-product-protection-for-industry-and-cosmetics/ 2023-08-22T11:04:38+00:00 https://old.international-pharma.com/wp-content/uploads/2023/08/Securikett-3.png https://old.international-pharma.com/wp-content/uploads/2023/08/Securikett-1.png https://old.international-pharma.com/wp-content/uploads/2023/08/Securikett-2.gif https://old.international-pharma.com/cymabay-begins-phase-3-liver-disease-study/ 2023-08-15T10:13:27+00:00 https://old.international-pharma.com/cnx-acquires-four-cancer-drugs-from-clinigen/ 2023-08-15T10:10:18+00:00 https://old.international-pharma.com/novartis-remibrutinib-shows-promise-for-patients-with-csu/ 2023-08-15T10:07:59+00:00 https://old.international-pharma.com/green-light-for-one-of-europes-largest-life-sciences-campus/ 2023-08-15T10:06:05+00:00 https://old.international-pharma.com/alzecure-delivers-positive-neurorestore-candidate-results/ 2023-08-15T10:04:34+00:00 https://old.international-pharma.com/cphi-milan-returns-to-fiera-milano-and-the-lombardy-pharma-region-for-2024/ 2023-08-15T08:37:31+00:00 https://old.international-pharma.com/wp-content/uploads/2023/08/CPHI_5717336-2-fiera-milano-new1.jpeg https://old.international-pharma.com/infex-candidate-nominated-for-cov-x-programme/ 2023-08-08T15:00:58+00:00 https://old.international-pharma.com/taiho-begins-latest-non-small-cell-lung-cancer-trial/ 2023-08-08T14:58:14+00:00 https://old.international-pharma.com/evox-therapeutics-reaches-gene-therapy-agreement/ 2023-08-08T14:55:51+00:00 https://old.international-pharma.com/theriva-biologics-reveals-positive-vcn-01-study-results/ 2023-08-08T14:52:41+00:00 https://old.international-pharma.com/partnership-aims-to-boost-mental-health-research/ 2023-08-08T14:49:03+00:00 https://old.international-pharma.com/tower-cold-chain-accelerates-growth-with-two-new-senior-appointments/ 2023-08-08T13:22:15+00:00 https://old.international-pharma.com/wp-content/uploads/2023/08/Tower_Karin-Van-Den-Brekel-Regional-Commercial-Manager-EMEA.jpg https://old.international-pharma.com/wp-content/uploads/2023/08/Tower_Niall-Walsh-Business-Development-Manager-Ireland.jpg https://old.international-pharma.com/invizius-gets-mhra-approval-for-h-guard-research/ 2023-08-01T14:11:23+00:00